Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$203.52 - $273.43 $9,158 - $12,304
-45 Reduced 5.01%
854 $231,000
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $147,903 - $214,717
899 New
899 $212,000
Q2 2022

Aug 11, 2022

SELL
$204.13 - $302.4 $202,292 - $299,678
-991 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $23,191 - $29,612
66 Added 7.14%
991 $373,000
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $3,726 - $4,583
10 Added 1.09%
925 $382,000
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $41,183 - $52,031
140 Added 18.06%
915 $338,000
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $193,494 - $232,097
775 New
775 $225,000
Q3 2019

Nov 14, 2019

SELL
$125.07 - $143.67 $787,065 - $904,115
-6,293 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$123.4 - $148.55 $84,282 - $101,459
-683 Reduced 9.79%
6,293 $893,000
Q1 2019

May 14, 2019

SELL
$104.82 - $146.73 $97,377 - $136,312
-929 Reduced 11.75%
6,976 $1.01 Million
Q4 2018

Feb 14, 2019

SELL
$105.09 - $137.23 $218,482 - $285,301
-2,079 Reduced 20.82%
7,905 $883,000
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $13,789 - $16,548
123 Added 1.25%
9,984 $1.34 Million
Q2 2018

Aug 14, 2018

SELL
$102.37 - $117.25 $24,773 - $28,374
-242 Reduced 2.4%
9,861 $1.11 Million
Q1 2018

May 15, 2018

BUY
$98.19 - $115.2 $70,402 - $82,598
717 Added 7.64%
10,103 $1.08 Million
Q4 2017

Feb 13, 2018

SELL
$100.43 - $118.09 $56,843 - $66,838
-566 Reduced 5.69%
9,386 $1.03 Million
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $962,557 - $1.09 Million
9,952
9,952 $1.08 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.